BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23512527)

  • 1. Psychosocial consequences of predictive genetic testing for Lynch syndrome and associations to surveillance behaviour in a 7-year follow-up study.
    Aktan-Collan K; Kääriäinen H; Järvinen H; Peltomäki P; Pylvänäinen K; Mecklin JP; Haukkala A
    Fam Cancer; 2013 Dec; 12(4):639-46. PubMed ID: 23512527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
    Järvinen HJ; Renkonen-Sinisalo L; Aktán-Collán K; Peltomäki P; Aaltonen LA; Mecklin JP
    J Clin Oncol; 2009 Oct; 27(28):4793-7. PubMed ID: 19720893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonoscopy use following mutation detection in Lynch syndrome: exploring a role for cancer screening in adaptation.
    Hadley DW; Ashida S; Jenkins JF; Calzone KA; Kirsch IR; Koehly LM
    Clin Genet; 2011 Apr; 79(4):321-8. PubMed ID: 21204803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term psychosocial and behavioral adjustment in individuals receiving genetic test results in Lynch syndrome.
    Esplen MJ; Wong J; Aronson M; Butler K; Rothenmund H; Semotiuk K; Madlensky L; Way C; Dicks E; Green J; Gallinger S
    Clin Genet; 2015 Jun; 87(6):525-32. PubMed ID: 25297893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uroepithelial and kidney carcinoma in Lynch syndrome.
    Aarnio M; Säily M; Juhola M; Gylling A; Peltomäki P; Järvinen HJ; Mecklin JP
    Fam Cancer; 2012 Sep; 11(3):395-401. PubMed ID: 22476430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance colonography for colorectal cancer screening in patients with Lynch syndrome gene mutation.
    Lim EJ; Leung C; Pitman A; Stella DL; Brown G; Slattery M; Marion K; Macrae F
    Fam Cancer; 2010 Dec; 9(4):555-61. PubMed ID: 20495877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis.
    Jenkins MA; Dowty JG; Ait Ouakrim D; Mathews JD; Hopper JL; Drouet Y; Lasset C; Bonadona V; Win AK
    J Clin Oncol; 2015 Feb; 33(4):326-31. PubMed ID: 25534380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands.
    Capelle LG; Van Grieken NC; Lingsma HF; Steyerberg EW; Klokman WJ; Bruno MJ; Vasen HF; Kuipers EJ
    Gastroenterology; 2010 Feb; 138(2):487-92. PubMed ID: 19900449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
    Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
    Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with decision-making on prophylactic hysterectomy and attitudes towards gynecological surveillance among women with Lynch syndrome (LS): a descriptive study.
    Kalamo MH; Mäenpää JU; Seppälä TT; Mecklin JP; Huhtala H; Sorvettula K; Pylvänäinen K; Staff S
    Fam Cancer; 2020 Apr; 19(2):177-182. PubMed ID: 31997047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study.
    Aktan-Collan K; Haukkala A; Mecklin JP; Uutela A; Kääriäinen H
    Int J Cancer; 2001 Aug; 93(4):608-11. PubMed ID: 11477567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can an online risk assessment tool for identification of hereditary colorectal cancer reach the at-risk population and influence screening compliance?].
    Schürmanns K; Gelos M; Felder G; Schneider R; Möslein G
    Dtsch Med Wochenschr; 2014 May; 139(18):935-40. PubMed ID: 24760714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.
    Burke W; Petersen G; Lynch P; Botkin J; Daly M; Garber J; Kahn MJ; McTiernan A; Offit K; Thomson E; Varricchio C
    JAMA; 1997 Mar; 277(11):915-9. PubMed ID: 9062331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer.
    Stormorken AT; Clark N; Grindedal E; Maehle L; Møller P
    Scand J Gastroenterol; 2007 May; 42(5):611-7. PubMed ID: 17454882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures.
    Wagner A; van Kessel I; Kriege MG; Tops CM; Wijnen JT; Vasen HF; van der Meer CA; van Oostrom II; Meijers-Heijboer H
    Fam Cancer; 2005; 4(4):295-300. PubMed ID: 16341806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and management of Lynch syndrome.
    Boland CR
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):851,873. PubMed ID: 18185481
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
    Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
    Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making a case for surveillance colonoscopy in Lynch syndrome.
    Lindor NM
    Colorectal Dis; 2009 Feb; 11(2):131-2. PubMed ID: 19160466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.